- Home
- ACRV vs RMTI Comparison
ACRV vs RMTI Comparison
Compare ACRV & RMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- RMTI
- Stock Information
- Founded
- ACRV 2018
- RMTI 1994
- Country
- ACRV United States
- RMTI United States
- Employees
- ACRV N/A
- RMTI N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- RMTI Biotechnology: Pharmaceutical Preparations
- Sector
- ACRV Health Care
- RMTI Health Care
- Exchange
- ACRV Nasdaq
- RMTI Nasdaq
- Market Cap
- ACRV 47.8M
- RMTI 41.0M
- IPO Year
- ACRV 2022
- RMTI 1998
- Fundamental
- Price
- ACRV $1.87
- RMTI $0.99
- Analyst Decision
- ACRV Buy
- RMTI Strong Buy
- Analyst Count
- ACRV 6
- RMTI 2
- Target Price
- ACRV $17.75
- RMTI $4.00
- AVG Volume (30 Days)
- ACRV 1.1M
- RMTI 439.2K
- Earning Date
- ACRV 11-07-2025
- RMTI 11-12-2025
- Dividend Yield
- ACRV N/A
- RMTI N/A
- EPS Growth
- ACRV N/A
- RMTI N/A
- EPS
- ACRV N/A
- RMTI N/A
- Revenue
- ACRV N/A
- RMTI $87,966,000.00
- Revenue This Year
- ACRV N/A
- RMTI N/A
- Revenue Next Year
- ACRV $805.34
- RMTI $10.99
- P/E Ratio
- ACRV N/A
- RMTI N/A
- Revenue Growth
- ACRV N/A
- RMTI N/A
- 52 Week Low
- ACRV $1.05
- RMTI $0.78
- 52 Week High
- ACRV $8.74
- RMTI $5.15
- Technical
- Relative Strength Index (RSI)
- ACRV 48.13
- RMTI 33.55
- Support Level
- ACRV $1.91
- RMTI $1.07
- Resistance Level
- ACRV $2.46
- RMTI $1.09
- Average True Range (ATR)
- ACRV 0.17
- RMTI 0.06
- MACD
- ACRV -0.02
- RMTI -0.01
- Stochastic Oscillator
- ACRV 15.69
- RMTI 20.04
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.